WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 1'1701 Infant (under 12 months) mortality rate: 192
GDP / capita (US$): 3'4271 Child (under 5 years) mortality rate: 212

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 5'956  5'865  5'775  5'684  5'594  4'921  4'373  3'611 
Births 150  152  153  152  150  106  137  115 
Surviving infants 148  149  150  149  146  101  128  106 
Pop. less than 5 years 760  748  732  709  679  538  628  479 
Pop. less than 15 years 1'877  1'824  1'777  1'731  1'688  1'719  1'637  1'334 
Female 15-49 years 1'538  1'536  1'533  1'531  1'528  1'281  1'024  853 

Number of reported cases

(Click for retrospective incidence data for Kyrgyzstan)
Diphtheria
ChartChart
  15 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  17'779  318  16  584 
Mumps
ChartChart
  318  563  694  350  350 
Pertussis
ChartChart
  195  90  62  34  237 
Polio*
ChartChart
 
Rubella
ChartChart
  100  24  12  176 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Kyrgyzstan)
Vaccine year result method % card seen                                                
BCG 2012  100  MICS   91  97  97  97  98  98  96 
DTP1 2012  98  MICS   91  97  99*  96  99  97  99 
DTP3 2012  96  MICS   91  96  97  96  97  96  99 
DTP4          98  86  95 
IPV1         
HepB_BD          97  97  99  96  94  45 
HepB3 2012  96  MICS   91  96  97  96  97  96  44 
Hib3 2012  96  MICS   91  96  97  96  97  96 
JapEnc         
MCV1          97  99  96  99  98  98 
MCV2          98  96  97  97  98  96 
MenA         
PCV1          75 
PCV2          41 
PCV3         
Pol3 2012  90  MICS   91  97  97  95  97  94  99 
Rota1         
RotaC         
RCV1          97  99  96  99 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Kyrgyzstan)
BCG
  97  97  97  98  98  96 
DTP1
  97  99  96  98  96  99 
DTP3
  96  97  96  97  96  99 
HepB3
  96  97  96  97  96  44 
HepB_BD
  96  97  99  96  94  45 
Hib3
  96  97  96  97  96 
IPV1
 
MCV1
  97  99  96  99  98  98 
MCV2
  98  96  97  97  98  96 
PCV3
 
Pol3
  97  97  95  97  94  99 
RCV1
  97  99  96  99  98 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 40  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 6 years; Yes
DTwP 2 years; Yes
DTwPHibHepB 2, 3.5, 5 months; Yes
HepB_Pediatric birth; Yes
IPV 3.5 months; Yes
MMR 12 months; 6 years; Yes
OPV 2, 3.5, 5 months; Yes
Pneumo_conj 2, 5, 12 months; Yes
Td 11, 16, 26, 36, 46, 56 years; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2012-2016  2013-2017  2006-2012  2011-2016  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 40  40  40  40    40  Yes 

System performance

Total Nº districts in country number 40  40  40  40  40  40  42 
Nº districts with DTP3 coverage >=80% number   40  40  40  40  40   
% of districts with DTP3 coverage >=80% From 0 to 100%   100  100  100  100  100   
Nº districts with measles (MCV1) coverage >=95% number   38    40  40  38  42 
% of districts with MCV1 coverage >=95% From 0 to 100%   95    100  100  95  100 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 27  50  13       

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.